Last reviewed · How we verify
Weight loss
This is a generic category ('weight loss') rather than a specific drug, so no single mechanism applies.
This is a generic category ('weight loss') rather than a specific drug, so no single mechanism applies. Used for Weight loss / Obesity management.
At a glance
| Generic name | Weight loss |
|---|---|
| Sponsor | University of Texas Southwestern Medical Center |
| Modality | Small molecule |
| Therapeutic area | Endocrinology / Obesity |
| Phase | FDA-approved |
Mechanism of action
Weight loss can be achieved through multiple mechanisms including GLP-1 receptor agonism, sympathomimetic stimulation, lipase inhibition, or other metabolic pathways. Without a specific drug name or molecular target, a precise mechanism cannot be determined. The University of Texas Southwestern Medical Center may be researching novel weight loss therapeutics, but the mechanism is not specified.
Approved indications
- Weight loss / Obesity management
Common side effects
Key clinical trials
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease (NA)
- A Study of a Weight Loss Intervention in People With Endometrial Cancer (EARLY_PHASE1)
- A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity
- Using Technology to Investigate Lapses in a Weight Loss Program Among Individuals With Overweight and Obesity (NA)
- Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
- Exercise for the Treatment of Cancer-Related Sarcopenia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Weight loss CI brief — competitive landscape report
- Weight loss updates RSS · CI watch RSS
- University of Texas Southwestern Medical Center portfolio CI